| Product Code: ETC11530658 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Companion Diagnostic Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Companion Diagnostic Market - Industry Life Cycle |
3.4 Poland Companion Diagnostic Market - Porter's Five Forces |
3.5 Poland Companion Diagnostic Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Poland Companion Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Poland Companion Diagnostic Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Poland Companion Diagnostic Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Poland Companion Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Poland Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Poland leading to a higher demand for companion diagnostics. |
4.2.2 Growing focus on personalized medicine and targeted therapies driving the adoption of companion diagnostics. |
4.2.3 Rising investments in healthcare infrastructure and research development activities supporting the growth of the companion diagnostic market in Poland. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for companion diagnostics may hinder market growth. |
4.3.2 Limited awareness and understanding among healthcare professionals and patients about the benefits of companion diagnostics. |
4.3.3 High costs associated with companion diagnostics tests and treatments could limit market penetration. |
5 Poland Companion Diagnostic Market Trends |
6 Poland Companion Diagnostic Market, By Types |
6.1 Poland Companion Diagnostic Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Companion Diagnostic Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Poland Companion Diagnostic Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Poland Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry, 2021 - 2031F |
6.1.5 Poland Companion Diagnostic Market Revenues & Volume, By Next-Gen Sequencing, 2021 - 2031F |
6.1.6 Poland Companion Diagnostic Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.2 Poland Companion Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Poland Companion Diagnostic Market Revenues & Volume, By Drug Response Testing, 2021 - 2031F |
6.2.3 Poland Companion Diagnostic Market Revenues & Volume, By Biomarker Testing, 2021 - 2031F |
6.2.4 Poland Companion Diagnostic Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.5 Poland Companion Diagnostic Market Revenues & Volume, By Disease Identification, 2021 - 2031F |
6.3 Poland Companion Diagnostic Market, By Disease Area |
6.3.1 Overview and Analysis |
6.3.2 Poland Companion Diagnostic Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Poland Companion Diagnostic Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.4 Poland Companion Diagnostic Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.5 Poland Companion Diagnostic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4 Poland Companion Diagnostic Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Poland Companion Diagnostic Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Poland Companion Diagnostic Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Poland Companion Diagnostic Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Poland Companion Diagnostic Market Revenues & Volume, By Urine, 2021 - 2031F |
6.5 Poland Companion Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Poland Companion Diagnostic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Poland Companion Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5.4 Poland Companion Diagnostic Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Poland Companion Diagnostic Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
7 Poland Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Poland Companion Diagnostic Market Export to Major Countries |
7.2 Poland Companion Diagnostic Market Imports from Major Countries |
8 Poland Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics by healthcare facilities in Poland. |
8.2 Number of clinical trials incorporating companion diagnostics in the country. |
8.3 Research and development expenditure on companion diagnostics technology advancements in Poland. |
9 Poland Companion Diagnostic Market - Opportunity Assessment |
9.1 Poland Companion Diagnostic Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Poland Companion Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Poland Companion Diagnostic Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.4 Poland Companion Diagnostic Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Poland Companion Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Poland Companion Diagnostic Market - Competitive Landscape |
10.1 Poland Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Poland Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here